Dr. Matthew J. Mifsud, MD

Dr. Mifsud practices at USFCenter for Advanced Healthcare in Tampa, Florida.

Dr. Mifsud's NPI, 1285953679, was assigned on May 25, 2010. Dr. Mifsud graduated from Tufts University School Of Medicine in 2010. Dr. Mifsud holds Florida license ME132370.

Dr. Mifsud's primary practice is USFCenter for Advanced Healthcare, at 13330 Usf Laurel Dr, Tampa, FL 33612 in Hillsborough County. The practice phone is (813) 974-2201.

Dr. Mifsud's primary practice is USFCenter for Advanced Healthcare in Tampa, Florida. Dr. Mifsud is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Mifsud to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mifsud practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Mifsud's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Mifsud is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Mifsud is licensed in Florida.

Dmand AI lists larynx and vocal cord disease and thyroid surgery among the conditions Dr. Mifsud treats.

CMS data shows 402 Medicare services from Dr. Mifsud across 7 procedure codes in 2024, for 232 Medicare patients. Medicare paid $29,878 for them. Every service was in an office.

CMS counts 232 Medicare patients who saw Dr. Mifsud in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mifsud's median patient age at 65, with 53% women.

In 2024, Dr. Mifsud wrote 126 Medicare Part D claims for 63 patients. 93% of them were for generic drugs. CMS names the drug for 53 of them, across 4 drugs with 11 or more claims each, at $876 in total drug cost. In 2023, CMS named 125 claims across 8 drugs.

Dr. Mifsud accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mifsud as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Mifsud, published from 2013 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Head and Neck Neoplasms, Postoperative Complications and Free Tissue Flaps. Dr. Mifsud has published most often in Head Neck. Dr. Mifsud's most frequent co-authors are Sepehr Shabani, MD, Abhay Sharma, MD and Abhay V. Sharma, MD.

CMS Open Payments shows 58 general payments to Dr. Mifsud from 14 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 66% of the total. Ethicon Inc. paid the most, $9,996.

Dmand AI lists 1 award for Dr. Mifsud.

Dr. Mifsud graduated from Tufts University School Of Medicine in 2010. Dr. Mifsud is a member of NHS.

Dr. Mifsud is in network with 21 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.